Hematologic malignancy (hemeonc) and bone marrow transplant (BMT) patients are at higher risk of central line associated bloodstream infection (CLABSI) due to their dependency on central lines for treatment” Dombecki et al (2017).
Background:
Hematologic malignancy (hemeonc) and bone marrow transplant (BMT) patients are at higher risk of central line associated bloodstream infection (CLABSI) due to their dependency on central lines for treatment. Special considerations need to be taken into account when developing effective strategies to prevent CLABSI in this patient population.
[ctt link=”3By67″ template=”1″]ReTweet if useful… CLABSI prevention bundle for adult haematological patients https://ctt.ec/3By67+ @ivteam #ivteam[/ctt]
Reference:
Dombecki, C., Vercher, J., Valyko, A., Mills, J. and Washer, L. (2017) Implementation of a Central Line-associated Bloodstream Infection (CLABSI) Prevention Bundle for Adult Hematologic Malignancy and Bone Marrow Transplant Patients. American Journal of Infection Control. 45(6), Supplement, p.S103.
DOI: http://dx.doi.org/10.1016/j.ajic.2017.04.166
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]